The Office for Human Research Protections (OHRP) has released a new document titled Guidance on Withdrawal of Subjects from Research: Data Retention and Other Related Issues.
The document offers answers to important questions about the meaning of subject withdrawal from research, as well as associated procedures. The OHRP also examines how this document may interact with similar FDA and HIPAA recommendations. What do you think of this new federal guidance? How might it apply to your work?